Trial Profile
A Clinical Trail to Investigate the Influence of SLCO2B1 Polymorphism on the Pharmacokinetic Characteristics of Voriconazole in CYP2C19 Poor Metabolizers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary) ; Voriconazole (Primary)
- Indications Aspergillosis; Candidiasis; Fusariosis; Mycoses
- Focus Pharmacogenomic; Pharmacokinetics
- 23 Oct 2017 Status changed from recruiting to completed.
- 28 Sep 2016 New trial record